Carbocine 450mg\45ml Injection

• Ovarian cancer and non small cell lung cancer

Every medication shows some side effects. Patient experience mild as well as severe side effects while using Carbocine 450mg Injection. Cosult the doctor before using the medication to avoid complications during the treatment. Common ones include:

• Loss of taste, diarrhea
• Constipation
• Hair loss
• Skin rashes
• Itchiness
• Extreme tiredness and weakness

• Reduced number of red blood cells (anemia)
• Allergic reactions
• Abnormal bruises
• Kidney problems
• Hearing problems
• Fever, chills

• Inflammation in lung tissues
• Tingling or numbness in your hands, arms, or legs
• Prickling sensation

• Carbocine 45ml Injection should be taken into the veins under the medical supervision of a healthcare professional. It must be taken at the same time everyday to improve the effectiveness of the medication.
• Do not miss or stop taking the injection without consultation with a doctor, as doing so may affect the effectiveness of the therapy and the overall treatment outcome.

• Carbocine 450mg Injection is a platinum based chemotherapy drug. It works by damaging cancer cells' DNA strands which stops them from diving and growing.
• This DNA damaged cannot be repaired properly, leading to the death of cancer cells through programmed cell death (apoptosis). By targeting it, the medicine reduces tumor growth and prevents the spread of cancer in the body.

• Stewart, D. J. (2007). Mechanisms of resistance to cisplatin and carboplatin. Critical reviews in oncology/hematology, 63(1), 12-31. https://pubmed.ncbi.nlm.nih.gov/17336087/
• van der Vijgh, W. J. (1991). Clinical pharmacokinetics of carboplatin. Clinical pharmacokinetics, 21(4), 242-261. https://pubmed.ncbi.nlm.nih.gov/1760899/
• Canetta, R., Rozencweig, M., & Carter, S. K. (1985). Carboplatin: the clinical spectrum to date. Cancer treatment reviews, 12, 125-136. https://pubmed.ncbi.nlm.nih.gov/3002623/
• Fox, L. E. (2000). Carboplatin. Journal of the American Animal Hospital Association, 36(1), 13-14. https://pubmed.ncbi.nlm.nih.gov/10667400/
• Go, R. S., & Adjei, A. A. (1999). Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. Journal of Clinical Oncology, 17(1), 409-409.